Category: Consumer Goods

You can add some category description here.

Tripple Gee & Company Plc reports a loss of N19.8 million in Q1 2021.

Chidi Emenike Leave a comment

Tripple Gee & Company Plc released its unaudited results for the first quarter of the year (Q1, 2021).

  • Turnover for the period was N461.4 million. (+48.8% YoY)
  • Cost of sales was N400.5 million. (+89.1% YoY)
  • Administrative expenses totalled N25.9 million. (-41.7% YoY)
  • Operating profit of N34.99 million. (-35.2% YoY)
  • Loss after tax of N19.81 million was incurred
  • Loss per share for the period was 4 kobo

See link to results.

Fidson Healthcare Plc grows profit by 281.4% to N579.6 million in Q1 2021.

Chidi Emenike Leave a comment

Fidson Healthcare Plc released its unaudited results for the first quarter of the year (Q1, 2021).

  • Revenue for the period was N6.3 billion. (+68.5% YoY)
  • Cost of sales was N3.48 billion. (+71.7% YoY)
  • Administrative expenses totalled N919.4 million. (+49% YoY)
  • Operating profit of N1.17 billion. (+111.5% YoY)
  • Profit for the period was N579.6 million. (+281.4% YoY)

See link to results.

May and Baker Nigeria Plc grows profit by 478% to N247.4 million in Q1 2021.

Chidi Emenike Leave a comment

May and Baker Nigeria Plc released its unaudited results for the first quarter of the year (Q1, 2021).

  • Revenue for the period was N2.7 billion. (+47.8% YoY)
  • Cost of sales was N1.56 billion. (+11.8% YoY)
  • Administrative expenses totalled N211.2 million. (+178.3% YoY)
  • Operating profit of N418.98 million. (+482.2% YoY)
  • Profit for the year was N247.4 million. (+478% YoY)
  • Earnings per share of 14 kobo Vs 2 kobo YoY.

See link to results.

GlaxoSmithKline Consumer Nigeria Plc reports a loss of N238.07 million in Q1 2021.

Chidi Emenike Leave a comment

GlaxoSmithKline Consumer Nigeria Plc released its unaudited results for the first quarter of the year (Q1, 2021).

  • Revenue for the period was N3.5 billion. (-30.6% YoY)
  • Cost of sales was N2.4 billion. (-30.6% YoY)
  • Administrative expenses totalled N502.96 million. (+0.3% YoY)
  • Loss for the period was N238.07 million
  • Loss per share from continuing operations was 20 kobo.

See link to results.

Livestock Feeds Plc Profit after tax surge by over 300% to N176.54 million in Q1 2021.

Chidi Emenike Leave a comment

Livestock Feeds Plc released its unaudited results for the first quarter of the year (Q1, 2021).

  • Revenue from contracts with customers was N3.35 billion. (+36% YoY)
  • Cost of sales was N2.95 billion. (+32.5% YoY)
  • Administrative expenses totalled N104.2 million. (+28.4% YoY)
  • Operating profit of N245.9 million. (+138.6% YoY)
  • Profit after tax was N176.54 million. (+335.9% YoY)
  • Earnings per share 6kobo Vs 1kobo YoY.

See link to results.

Pharma Deko Plc records a loss of N6.5 million in Q1 2021.

Chidi Emenike Leave a comment

Pharma Deko Plc released its unaudited results for the first quarter of the year (Q1, 2021).

  • Revenue for the period was N150.5 Million. (+65% YoY)
  • Cost of sales was N110.95 million. (+59% YoY)
  • Administrative expenses totalled N41.3 million. (-51% YoY)
  • A loss after tax of N6.5 million was incurred.
  • Total assets stood at N1.95 billion (-8% YoY)
  • Loss per share of -3 kobo Vs -40 kobo YoY.

See link to results.

Cadbury Nigeria Plc records a 62% decline in profit to N60.2 million in Q1 2021.

Chidi Emenike Leave a comment

Cadbury Nigeria Plc released its unaudited results for the first quarter of the year (Q1, 2021).

  • Revenue for the period was N8.9 billion. (+4.3% YoY)
  • Cost of sales was N7.4 billion. (+18.6% YoY)
  • Administrative expenses totalled N274.4 million. (-19.2% YoY)
  • Profit for the period was N60.2 million. (-62.2% YoY)
  • Earnings per share of 13 kobo Vs 34 kobo YoY.
  • Net assets per share was N7.34

See link to results.

Glaxo SmithKline proposes dividend worth N478.4 million for shareholders.

Chidi Emenike Leave a comment

The Board of Directors of Glaxo Smith Kline Plc has proposed a sum of N478.4 million as dividend to be paid to shareholders for the period ended 31st of December 2020.

This is according to a disclosure signed by the company’s secretary, Uchenna Uwechia and sent to the Nigerian Exchange Group.

According to the notice, the approval of the proposed dividends will see the pharmaceutical firm pay out a dividend of 40 kobo for each of the outstanding 1,195,876,488 ordinary shares of the company, held by its shareholders.

It is pertinent to note that the proposed dividend for the period is less than the sum of N657.7million proposed and paid in corresponding period last year (55 kobo per share). This is attributable to a decline recorded in key financial metrics for the period, such as: PAT (-32.2% YoY), EPS (-32.5% YoY) etc.

Ceteris Paribus, the proposed dividend if ratified will be disbursed to qualified shareholders’ on 28th of May, 2021.  The qualified shareholders are those, whose names appear in the Register of Members as at close of trading on 23rd of April, 2021. Sequel to this, the Register of Members will be closed from 26th-30th of April, 2021 with both dates inclusive.

In addition, shareholders are urged to complete the e-dividend registration and submit to the Registrar (Greenwich Registrars and Data Solutions Limited).

What you should know:

  • Glaxo SmithKline earlier reported a profit after tax of N622.2 million in FY 2020.
  • The firm will convey an Annual General Meeting on 27th of May, 2021 at GSK House, Ilupeju- Lagos to discuss and approve the proposed dividend.
  • The firm closed trading for the week ended 23rd of April, 2021 with a share price of N6.5

For more information about the proposed dividend, click HERE.

GlaxoSmithKline (GSK) announces Annual General Meeting.

Chidi Emenike Leave a comment

The Board of Unilever GlaxoSmithKline Plc has announced that it will host its Annual General Meeting on the 27th of May, 2021.

According to a notice issued by the company and seen by Nairametrics, the meeting will hold at the company’s head office at 1 Industrial Avenue, Ilupeju-Lagos by 11:00am. Sequel to this, the following issues will be discussed;

  • To consider the audited financial statements of the company for the period ended 31st December 2020, and declare a dividend.
  • To fix Auditors and Directors remuneration for the year 2021.
  • To approve a general mandate authorizing the company to procure goods and services for its operational activities during the year, from related parties or interested persons on normal commercial terms consistent with the NSE Rules Governing Transactions.
  • To elect members of the audit committee.
  • To consider and ratify board appointments.

What you should know:

  • In line with CAC guidelines, the AGM will be conducted through the use of proxies. Sequel to this, a list of comprising of 8 proxies was made public the company, available for members (shareholders) to choose from.
  • Recall that GSK Plc had recently declared a profit after tax of N622.2 million in FY 2020.

For more information about the AGM, click HERE.